Model
Digital Document
Publisher
Florida Atlantic University
Description
Matrix metalloproteinases MMPs are a family of proteolytic enzymes that mediate the degradation of
various components of the extracellular matrix. Their functions are essential for normal physiological
processes such as wound healing, but their dysregulation is associated with various pathologies
including autoimmune diseases such as Multiple Sclerosis MS. Experimental Autoimmune
Encephalomyelitis EAE is a well-established murine model of MS that is mediated by CD4 T-cells.
These cells penetrate the blood-brain-barrier BBB, recruit other immune cells, initiate destruction of the
myelin sheath, and cause axonal loss. MMP-9 is a hallmark enzyme in progression of MS that is
required for penetration of the BBB and generation of autoantigens in EAE. In addition, recent studies
have demonstrated that MMP-9 contributes to normal intracellular function of various cell types
including antigen activated T-cells; however, the intracellular role of MMP-9 in immune cell activation
during EAE pathogenesis is not known. In this study, we used a highly selective MMP-9 triple-helical
peptide inhibitor THPI that is a phosphinate transition state analog to examine antigen specific T-cell
responses. We found that selective inhibition of MMP-9 can mitigate pathogenic T-cell activity and
cellular trafficking as well as the clinical severity of EAE, suggesting that selective MMP-9 inhibition in
MS can be a potent therapeutic option.
various components of the extracellular matrix. Their functions are essential for normal physiological
processes such as wound healing, but their dysregulation is associated with various pathologies
including autoimmune diseases such as Multiple Sclerosis MS. Experimental Autoimmune
Encephalomyelitis EAE is a well-established murine model of MS that is mediated by CD4 T-cells.
These cells penetrate the blood-brain-barrier BBB, recruit other immune cells, initiate destruction of the
myelin sheath, and cause axonal loss. MMP-9 is a hallmark enzyme in progression of MS that is
required for penetration of the BBB and generation of autoantigens in EAE. In addition, recent studies
have demonstrated that MMP-9 contributes to normal intracellular function of various cell types
including antigen activated T-cells; however, the intracellular role of MMP-9 in immune cell activation
during EAE pathogenesis is not known. In this study, we used a highly selective MMP-9 triple-helical
peptide inhibitor THPI that is a phosphinate transition state analog to examine antigen specific T-cell
responses. We found that selective inhibition of MMP-9 can mitigate pathogenic T-cell activity and
cellular trafficking as well as the clinical severity of EAE, suggesting that selective MMP-9 inhibition in
MS can be a potent therapeutic option.
Member of